肝内胆管癌患者根治性手术后肝衰竭和复发的术前危险因素分析OACSTPCD
Preoperative risk factors for postoperative liver failure and recurrence in intrahepatic cholangiocarcinoma patients who underwent radical resection
目的 通过术前临床因素预测肝内胆管癌(ICC)患者术后发生肝衰竭和1年内复发的危险因素.方法 回顾性分析2017年6月至2022年6月于郑州大学人民医院肝胆胰腺外科行根治术的ICC患者的临床资料.根据患者术后肝功能指标将患者分为术后肝衰竭组(n=16)和非肝衰竭组(n=40);按术后1年内是否复发将其分为复发组(n=22)和未复发组(n=34).采用单因素检验(t检验和χ2检验)分析ICC术后复发和肝衰竭的危险因素.计算血肌酐与胱抑素比值(CCR)预测ICC术后1年内复发和肝衰竭的受试者工作特征(ROC)曲线下面积(AUC),将约登指数最大时的CCR值作为最佳临界值.采用多因素Logistic回归分析患者ICC术后发生肝衰竭和1年内复发的独立危险因素.结果 CCR在复发组和非复发组[(53.49±3.90)vs(72.46±2.10)]、肝衰竭组和非肝衰竭组[(54.67±4.49)vs(69.14±2.48)]中差异均有统计学意义(均P<0.05),此外体质量减轻≥5 kg、肝炎病毒定量≥104 IU/ML、肿瘤低分化、肿瘤最大径≥5 cm、肿瘤数目多发、有淋巴结转移是ICC患者术后1年内复发的相关因素;体质量减轻≥5 kg、肝炎病毒定量≥104 IU/mL、肿瘤最大径≥5 cm、肿瘤数目多发、既往胆管疾病史是其术后肝衰竭的相关因素(均P<0.05).ROC曲线分析显示CCR预测ICC术后1年内复发和肝衰竭的AUC分别为0.814和0.720(均P<0.05),CCR的最佳临界值分别为62.34和64.82.多因素Logistic回归分析结果表明CCR低(OR=22.357,95%CI 1.140-438.308)、肿瘤数目多发(OR=27.050,95%CI 1.029-711.165)、有淋巴结转移(OR=18.046,95%CI 1.333-244.389)、肿瘤分化程度低(OR=18.134,95%CI 1.357-242.359)是ICC术后1年内复发的独立危险因素;肿瘤最大径≥5 cm(OR=8.800,95%CI 2.373-32.635)是ICC术后发生肝衰竭的独立危险因素.结论 CCR可作为一种术前预测ICC患者术后肝衰竭和术后1年内复发的临床指标.
Objective To predict the risk factors of postoperative liver failure and recurrence within 1 year for intrahepatic cholangiocarcinoma(ICC)patients who underwent radical resection based on preoperative clinical factors.Methods The clinical data of patients with ICC who underwent radical resection at the People's Hospital of Zhengzhou University from Jun.2017 to Jun.2022,were retrospectively analyzed.According to the postoperative liver function index,56 patients were divided into postoperative liver failure group(n=16)and non-liver failure group(n=40);According to the recurrence status within 1 year after radical resection,this 56 patients were divided into recurrence group(n=22)and non-recurrence group(n=34).Univariate analysis was used to explore risk factors for postoperative liver failure and recurrence within 1 year.The area under the receiver operating characteristic(ROC)curve(AUC)of serum creatinine to cystatin ratio(CCR)in predicting ICC recurrence within 1 year and postoperative liver failure were calculated.The value of CCR at the maximum Youden index was considered as the optimal cut-off point.Multivariate Logistic regression analysis was used to explore the independent risk factors for postoperative liver failure and recurrence within 1 year after radical resection.Results Univariate analysis shewed that there was significant difference in CCR between the recurrence group and non-recurrence group[(53.49±3.90)vs(72.46±2.10)],as well as between the liver failure group and non-liver failure group[(54.67±4.49)vs(69.14±2.48)](all P<0.05).Weight loss≥5 kg,hepatitis virus quantitation≥104 IU/ML,poor tumor differentiation,tumor maximum diameter≥5 cm,multiple tumor number,and lymph node metastasis were relevant factors for recurrence within 1 year after radical resection.Similarly,weight loss≥5 kg,hepatitis virus quantification≥104 IU/mL,tumor maximum diameter≥5 cm,multiple tumor number,and previous history of bile duct disease were identified as relevant factors for postoperative liver failure.ROC curve analysis showed that the AUCs were 0.814 and 0.720 for CCR in predicting recurrence and postoperative liver failure,respectively(all P<0.05);and the optimal cut-off points were 62.34 and 64.82,respectively.Multivariate Logistic regression analysis showed that low CCR(OR=22.357,95%CI 1.140-438.308),multiple tumor number(OR=27.050,95%CI 1.029-711.165),lymph node metastasis(OR=18.046,95%CI 1.029-711.165),and poor tumor differentiation(OR=18.134,95%CI 1.357-242.359)were independent risk factors for ICC recurrence within 1 year after radical resection.Tumor maximum diameter≥5 cm(OR=8.800,95%CI 2.373-32.635)was an independent risk factor for liver failure after radical resection.Conclusion For patients with ICC,CCR can be used as a preoperative clinical index to predict postoperative liver failure and recurrence within 1 year after radical resection.
陈磊;何超;刘攀;付强;罗乾坤;张宏伟;秦涛
郑州大学人民医院 肝胆胰腺外科,河南 郑州 450003
临床医学
肝内胆管癌术后肝衰竭复发血肌酐与胱抑素C比值术前预测
intrahepatic cholangiocarcinomapostoperative liver failurerecurrencereatinine-cystatin c ratiopreoperative prediction
《肝胆胰外科杂志》 2024 (003)
胰腺腺泡细胞凋亡相关微小RNA-22和微小RNA-135a调控机制研究
150-154 / 5
国家自然科学基金项目(31671440).
评论